ontilyv
bial portela & companhia s.a. - opicapone - choroba parkinsona - leki przeciw chorobie parkinsona - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
alikval duo 50 mg + 850 mg tabletki powlekane
egis pharmaceuticals plc - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
alikval duo 50 mg + 1000 mg tabletki powlekane
egis pharmaceuticals plc - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
vildagliptin + metformin hydrochloride +pharma 50 mg + 850 mg tabletki powlekane
+pharma arzneimittel gmbh - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
vildagliptin + metformin hydrochloride +pharma 50 mg + 1000 mg tabletki powlekane
+pharma arzneimittel gmbh - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
jansitin duo 50 mg + 1000 mg tabletki powlekane
g.l. pharma gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
jansitin duo 50 mg + 850 mg tabletki powlekane
g.l. pharma gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
sitagliptin + metformin hydrochloride tzf 50 mg + 1000 mg tabletki powlekane
tarchomińskie zakłady farmaceutyczne "polfa" s.a. - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg